Disclosure: This is an affiliate site. We may earn compensation from partners. Full disclosure | Medical disclaimer
Published $200/mo compounded pricing with no subscription, in English or Spanish
Also searched as: Body Forward
$200/mo
Compounded
Cash-pay
August 30, 2026
BodyForward is a licensed US telehealth service offering doctor-prescribed compounded semaglutide with what it describes as transparent pricing from $200 a month and no subscriptions.
The proposition is simple and the pricing is published, which puts it ahead of several competitors that hide cost behind a quiz. There is no membership layered on top of the medication price.
It also runs a Spanish-language site covering GLP-1 telemedicine, describing how the medications support the body's natural appetite and blood-sugar regulation — making it one of a small number of providers offering the service in Spanish.
BodyForward dispenses compounded semaglutide, which is not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness or quality.
Online consultation with a licensed US provider, included in the monthly price.
Adults meeting standard GLP-1 criteria as assessed by the prescribing provider.
Licensed US providers prescribe and manage the treatment, included in the price.
Not publicly listed as a standard requirement.
Compounding pharmacies. Specific partners are not publicly named.
Medication shipped to your address. Specific terms are not publicly detailed; injectable compounded GLP-1s require refrigerated handling.
Provider access included. Spanish-language service available.
None. BodyForward states its pricing carries no subscriptions.
From $200 a month for compounded semaglutide, inclusive of the provider consultation.
No subscription to cancel. Confirm specific terms before purchase.
Not publicly confirmed in the material we reviewed.
Not accepted. Compounded GLP-1s are not FDA-approved and are not insurance-eligible.
Reimbursement for compounded medication is uncertain. Confirm with your plan administrator.
Pricing in this review reflects what BodyForward and named third-party sources published as of August 30, 2026. Telehealth pricing changes frequently — confirm the current figure at checkout before you buy.
Spanish-speaking patients who want an all-in compounded programme with published pricing, and anyone who wants to avoid subscriptions and quiz-gated checkouts.
Semaglutide only — there is no tirzepatide pathway, which matters given the head-to-head evidence favours tirzepatide for weight loss. At $200 a month it also sits above several all-in competitors.
Compounded semaglutide starts at $200 a month, with the company describing transparent pricing and no subscriptions. The provider consultation is included in that price.
Yes. It runs a Spanish-language site covering its GLP-1 telemedicine service, which puts it in a small group of compounded providers offering care in Spanish.
No. The company states its pricing carries no subscriptions.
Its published offering is compounded semaglutide. We found no published tirzepatide programme, which is worth knowing given the SURMOUNT-5 head-to-head found tirzepatide produced greater average weight loss.
No. BodyForward dispenses compounded semaglutide, which is not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness or quality.
Every pricing and policy claim on this page traces back to one of these sources, checked on August 30, 2026.
Transparent published pricing, no subscription
BodyForward states no subscriptions
Verified August 30, 2026. Prices change often — confirm before purchase.
Share your experience with BodyForward to help others make informed decisions.
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with serious potential side effects and are not appropriate for everyone. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Compounded medications are not FDA-approved. The FDA does not evaluate compounded products for safety, effectiveness, or quality. Individual results vary. This page contains affiliate links, and we may earn compensation if you use them.
Date reviewed: August 30, 2026